Table 1 Characteristics of the study population
From: Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression
Number | 40 |
Age, years | 71 ± 13 |
Male gender, number (percentage) | 21 (53) |
Body mass index, kg/m2 | 28 ± 7 |
Premorbidities, number (percentage) | |
Chronic arterial hypertension | 23 (58) |
Obstructive coronary artery disease | 10 (25) |
Compensated congestive heart failure | 12 (30) |
Chronic obstructive pulmonary disease | 8 (20) |
Chronic renal insufficiency | 14 (35) |
Chronic liver disease | 4 (10) |
Neoplasm | 3 (8) |
Chronic beta-blocker therapy, number (percentage) | 15 (38) |
Source of infection, number (percentage) | |
Liver/Abdomen | 21 (53) |
Lung | 10 (25) |
Skin/Soft tissue | 3 (8) |
Joint/Bone | 2 (5) |
Catheter/Device | 1 (3) |
Urogenital tract | 1 (3) |
Unknown origin | 2 (5) |
Continuous veno-venous hemofiltration, number (percentage) | 28 (70) |
Multiple organ dysfunction syndrome score (12), points | 9.9 ± 2.3 |
Simplified Acute Physiology Score II, points | 53 ± 16 |
Intensive care unit length of stay, days | 15 ± 11 |
28-day mortality, number (percentage) | 13 (33) |